Clinical documentation and data transfer from ebola and marburg virus disease wards in outbreak settings: Health care workers' experiences and preferences

Viruses

Volumn 6, Issue 2, 2014, Pages 927-937

  Bühler, Silja ^a,b   Roddy, Paul ^c   Nolte, Ellen ^a,d   Borchert, Matthias ^a,e  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c MÉDECINS SANS FRONTIÈRES   (Switzerland)

^d RAND CORPORATION   (United States)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Clinical documentation; Data transfer; Ebola hemorrhagic fever; Ebola virus disease; Isolation wards; Marburg hemorrhagic fever; Marburg virus disease; Viral hemorrhagic fever

Indexed keywords

CHLORINE; FORMALDEHYDE;

ARTICLE; CHLORINATION; DATA COLLECTION METHOD; DEATH; DISINFECTION; EBOLA HEMORRHAGIC FEVER; EPIDEMIC; FUMIGATION; HEALTH CARE PERSONNEL; HUMAN; MARBURG HEMORRHAGIC FEVER; MEDICAL DOCUMENTATION; MEDICAL PRACTICE; MEDICAL RECORD; PATIENT CARE; PATIENT SAFETY; PERSONAL EXPERIENCE; SEMI STRUCTURED INTERVIEW; ULTRAVIOLET RADIATION;

AFRICA SOUTH OF THE SAHARA; ANIMALS; ATTITUDE OF HEALTH PERSONNEL; DISEASE OUTBREAKS; DISINFECTION; ELECTRONIC HEALTH RECORDS; HEALTH PERSONNEL; HEMORRHAGIC FEVER, EBOLA; HUMANS; INTERVIEWS AS TOPIC; MARBURG VIRUS DISEASE; PATIENT ISOLATION;

EID: 84895137292     PISSN: 19994915     EISSN: None     Source Type: Journal    
DOI: 10.3390/v6020927     Document Type: Article

References (13)

1. Heymann, D.L. Control of Communicable Diseases Manual, 18th ed.; American Public Health Association: Washington, DC, USA, 2004; pp. 180-182.
2. Dowell, S.F.; Mukunu, R.; Ksiazek, T.G.; Khan, A.S.; Rollin, P.E.; Peters, C.J. Transmission of Ebola hemorrhagic fever: A study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidemies a Kikwit. J. Infect. Dis. 1999, 179, S87-S91.
3. Médecins Sans Frontières. Marburg hemorrhagic Fever outbreak. Uige-Angola April-July 2005 MSF OCBA, Internal Report; Médecins Sans Frontières: Barcelona, Spain, 2005.
4. Bausch, D.G.; Sprecher, A.G.; Jeffs, B.; Boumandouki, P. Treatment of Marburg and Ebola hemorrhagic fevers: A strategy for testing new drugs and vaccines under outbreak conditions. Antivir. Res. 2008, 78, 150-161.
5. Colebunders, R.; Tshomba, A.; van Kerkhove, M.D.; Bausch, D.G.; Campbell, P.; Libande, M; Pirard, P.; Tshioko, F.; Mardel, S.; Mulangu, S.; et al Marburg hemorrhagic fever in Durba and Watsa, Democratic Republic of the Congo: Clinical documentation, features of illness, and treatment. J. Infect. Dis. 2007, 196, S148-S153.
6. Jeffs, B.; Roddy, P.; Weatherill, D.; de la Rosa, O.; Dorion, C.; Iscla, M.; Grovas, I.; Palma, P.P.; Villa, L., Bernal, O.; et al The Medecins Sans Frontieres intervention in the Marburg hemorrhagic fever epidemic, Uige, Angola, 2005. I. Lessons learned in the hospital. J. Infect. Dis. 2007, 196, S154-S161.
7. Guimard, Y.; Bwaka, M.A.; Colebunders, R.; Calain, P.; Massamba, M.; De Roo, A.; Mupapa, K.D.; Kibadi, K.; Kuvula, K.J.; Ndaberey, D.E.; et al Organization of patient care during the Ebola hemorrhagic fever epidemic in Kikwit, Democratic Republic of the Congo, 1995. J. Infect. Dis. 1999, 179, S268-S273.
8. Roddy, P.; Colebunders, J.; Jeffs, B.; Palma, P.P.; van Herp, M.; Borchert, M. Filovirus hemorrhagic fever outbreak case management: A review of current and future treatment options. J. Infect. Dis. 2011, 204, S791-S795.
9. The group of interviewees was composed of HCWs from Médecins sans Frontières (Spain, Belgium, and Switzerland), Centers for Disease Control and Prevention (USA), WHO (Headquarters, Switzerland and Nigeria), Robert Koch-Institut (Germany), Health and Safety Executive (UK), Health Protection Agency (UK), Institute of Tropical Medicine Antwerp (Belgium), Leiden University Medical Center (The Netherlands) and independent nurses/clinicians. The views expressed in the interviews are views of individuals and not of their respective organisations.
10. Sagripanti, J.L.; Lytle, C.D. Sensitivity to ultraviolet radiation of Lassa, vaccinia, and Ebola viruses dried on surfaces. Arch. Virol 2011, 156, 489-494.
11. Nalgene® Polyolefin Plastic Paper Sheets. Supplier: Thermo Scientific [Internet]. Available online: https://us.vwr.com/store/catalog/product.jsp?catalog_number=51280-114 (accessed on 21 November 2013).
12. Bente, D.A.; Friesen, J.; White, K.; Koll, J.; Kobinger, G.P. A computerized data-capture system for animal biosafety level 4 laboratories. J. Am. Assoc. Lab. Anim. Sci 2011, 50, 660-664.
13. Bausch, D.G.; Towner, J.S.; Dowell, S.F.; Kaducu, F.; Lukwiya, M.; Sanchez, A., Nichil, S.T.; Ksiazek, T.G., Rollin, P.E.; et al Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J. Infect. Dis. 2007, 196, S142-S147.